Good Sunday morning, and welcome back to “Brunch,” a pop-up newsletter about the 2026 Election Cycle and more. There are nine ...

HUTCHMED announced positive results from the global Phase III SAFFRON trial, demonstrating that the combination of ORPATHYS® ...

— Establishes ORPATHYS® plus TAGRISSO® as an important targeted strategy to address MET-driven resistance following progression on prior EGFR TKI treatment — ...

She has been privately renting since 2017, after having to sell her home following the end of a relationship, and currently ...

Levels of anxiety and depression are soaring and ADHD prescriptions have risen to record levels - but experts believe wider ...